Use of SGLT-2 Inhibitors in Adults (Age 65) with Type 2 Diabetes and Cardiovascular Disease is Lower in Alberta and Manitoba than in Ontario (2018-2020): A Cross-Sectional Study of Different Drug Funding Policies

Posted date: September 30, 2024

Use of SGLT-2 Inhibitors in Adults (Age 65) with Type 2 Diabetes and Cardiovascular Disease is Lower in Alberta and Manitoba than in Ontario (2018-2020): A Cross-Sectional Study of Different Drug Funding Policies.

McCreary ML, Yeung RO, Manca DP, Greiver M, Singer AG, Lau D.Can J Diabetes. 2024 Sep 18:S1499-2671(24)00181-3. doi: 10.1016/j.jcjd.2024.09.003. PMID: 39303780

This study examines the lower utilization of sodium-glucose cotransporter-2 (SGLT-2) inhibitors in adults aged 65 and older with type 2 diabetes and cardiovascular disease in Alberta and Manitoba compared to Ontario, exploring the impact of different drug funding policies on medication access. The findings highlight regional disparities in access to life-saving diabetes medications. Diabetes Action Canada supported this research by providing access to the NDR, promoting policy analysis and advocating for equitable access to diabetes treatments across Canada.

Associated Programs

Digital Health

Using health data to better understand those living with diabetes and transform diabetes self-management.

Using Data to Change Lives

Episode six features Kylie Peacock, a Diabetes Action Canada Patient Partner and Conrad Pow, a Senior Project Manager at Diabetes Action Canada discussing the National Diabetes Repository and how Diabetes Action Canada is using data to change lives.

Using data to improve health care

Episode four discusses how we can use data to improve health care. Guests Devin Cleary and Dr. Alanna Weisman discuss their research projects in this area – in particular how they are trying to improve outcomes for people with type 1 diabetes.

Diabetes Research Connect Launches

National data repository now available to diabetes researchers This week, Diabetes Research Connect, a national, virtual data repository, launched. The data repository, a collaboration between Diabetes Action Canada and the Canadian Primary Care Sentinel Surveillance Network (CPCSSN), aims to enhance diabetes research across Canada and foster partnerships with academic institutions, healthcare providers and patient groups. […]